| Pharmaceutical active ingredients: |
| Quinidine |
| Available forms, composition and doses of Conquinine: |
| N / A |
| Conquinine medical category: |
| Human:Cardiac drugsClass IA antiarrythmics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BA01 - Quinidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Conion | Laureth-9 | Unidentified Pharmaceutical Company |
| Conjucain | Oxybuprocaine | Unidentified Pharmaceutical Company |
| Conjuncain | Oxybuprocaine | Unidentified Pharmaceutical Company |
| Conludaf | Norethindrone | Unidentified Pharmaceutical Company |
| Conosol C 200 | Mineral Oil | Unidentified Pharmaceutical Company |
| Conraxin H | Iodamide Meglumine | Unidentified Pharmaceutical Company |
| Conray 35 | Diatrizoate | Unidentified Pharmaceutical Company |
| Consenil | Ethaverine | Unidentified Pharmaceutical Company |
| Conserve | Spinosad | Unidentified Pharmaceutical Company |
| Consist | Trifloxystrobin | Unidentified Pharmaceutical Company |